Electrocardiographic (ECG) Safety Study of Droxidopa at Clinical and Supratherapeutic Dose

This study has been completed.
Sponsor:
Information provided by (Responsible Party):
Chelsea Therapeutics
ClinicalTrials.gov Identifier:
NCT01327066
First received: March 30, 2011
Last updated: March 6, 2012
Last verified: March 2012
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been completed.
  Study Completion Date: June 2011
  Primary Completion Date: April 2011 (Final data collection date for primary outcome measure)